Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1983 Feb;75(2):218–223.

Cephalosporins: Recent Developments

Ashir Kumar
PMCID: PMC2561450  PMID: 6827615

Abstract

Cephalosporin antibiotics have attained a significant role in managing bacterial diseases. The author discusses the second- and third-generation cephalosporins in this review.

Full text

PDF
218

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belohradsky B. H., Bruch K., Geiss D., Kafetzis D., Marget W., Peters G. Intravenous cefotaxime in children with bacterial meningitis. Lancet. 1980 Jan 12;1(8159):61–63. doi: 10.1016/s0140-6736(80)90491-2. [DOI] [PubMed] [Google Scholar]
  2. CHANG T. W., WEINSTEIN L. MORPHOLOGICAL CHANGES IN GRAM-NEGATIVE BACILLI EXPOSED TO CEPHALOTHIN. J Bacteriol. 1964 Dec;88:1790–1797. doi: 10.1128/jb.88.6.1790-1797.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ginsburg C. M., McCracken G. H., Jr Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics. J Pediatr. 1980 Feb;96(2):340–342. doi: 10.1016/s0022-3476(80)80843-2. [DOI] [PubMed] [Google Scholar]
  4. Ginsburg C. M., McCracken G. H., Jr, Clahsen J. C., Thomas M. L. Clinical pharmacology of cefadroxil in infants and children. Antimicrob Agents Chemother. 1978 May;13(5):845–848. doi: 10.1128/aac.13.5.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hall W. H., Opfer B. J., Gerding D. N. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Antimicrob Agents Chemother. 1980 Feb;17(2):273–279. doi: 10.1128/aac.17.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kaplan S. L., Mason E. O., Jr, Garcia H., Kvernland S. J., Loiselle E. M., Anderson D. C., Mintz A. A., Feigin R. D. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr. 1981 Jan;98(1):152–157. doi: 10.1016/s0022-3476(81)80562-8. [DOI] [PubMed] [Google Scholar]
  7. Kumar A., Aziz M. T. Moxalactam in treatment of recurrent Escherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia. Drug Intell Clin Pharm. 1981 Jan;15(1):50–51. doi: 10.1177/106002808101500109. [DOI] [PubMed] [Google Scholar]
  8. McCracken G. H., Jr, Ginsburg C. M., Clahsen J. C., Thomas M. L. Pharmacokinetics of cefaclor in infants and children. J Antimicrob Chemother. 1978 Nov;4(6):515–521. doi: 10.1093/jac/4.6.515. [DOI] [PubMed] [Google Scholar]
  9. Nelson J. D., Ginsburg C. M., Clahsen J. C., Jackson L. H. Treatment of acute otitis media of infancy with cefaclor. Am J Dis Child. 1978 Oct;132(10):992–996. doi: 10.1001/archpedi.1978.02120350056011. [DOI] [PubMed] [Google Scholar]
  10. Neu H. C. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis. 1978 May;137 (Suppl):S80–S87. doi: 10.1093/infdis/137.supplement.s80. [DOI] [PubMed] [Google Scholar]
  11. Santos J. I., Jacobson J. A., Swensen P., Palmer W. M. Cellulitis: treatment with cefoxitin compared with multiple antibiotic therapy. Pediatrics. 1981 Jun;67(6):887–890. [PubMed] [Google Scholar]
  12. Schaad U. B., McCracken G. H., Jr, Threlkeld N., Thomas M. L. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr. 1981 Jan;98(1):129–136. doi: 10.1016/s0022-3476(81)80559-8. [DOI] [PubMed] [Google Scholar]
  13. Sosna J. P., Murray P. R., Medoff G. Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother. 1978 Dec;14(6):876–879. doi: 10.1128/aac.14.6.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stapley E. O., Birnbaum J., Miller A. K., Wallick H., Hendlin D., Woodruff H. B. Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis. 1979 Jan-Feb;1(1):73–89. doi: 10.1093/clinids/1.1.73. [DOI] [PubMed] [Google Scholar]
  15. Thirumoorthi M. C., Dajani A. S., Vincent C. V., Maurer M. J. Pharmacology, Safety, and efficacy of cefamandole in childhood infections. Antimicrob Agents Chemother. 1981 Jul;20(1):21–24. doi: 10.1128/aac.20.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Waterman N. G., Eickenberg H. U., Scharfenberger L. Concentration of cefamandole in serum interstitial fluid, bile, and urine. Antimicrob Agents Chemother. 1976 Oct;10(4):733–735. doi: 10.1128/aac.10.4.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wise R., Andrews J. M., Bedford K. A. LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics. Antimicrob Agents Chemother. 1979 Sep;16(3):341–345. doi: 10.1128/aac.16.3.341. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES